Fundraising Fox

IconOVir Bio

New York, US · Founded 2018 · Delaware corporation · 3 known investors

iconovir.com ↗
Biotechin /iconovir-bio

Founders & leadership

DC
David ChangDirector, Promoter
HK
Helen KimDirector
SA
Sean AlgeoExecutive Officer, Promoter
JL
Jakob LovenDirector
MA
Mark A. McCamishExecutive Officer, Director
JK
Joshua KazamDirector
DM
David M. TanenExecutive Officer, Promoter
AS
Arie S. BelldegrunDirector, Promoter

Investors · 3

GV (Google Ventures)Mountain View · $250K – $50M
Nextech InvestZurich · $648K – $3.2M
Vida VenturesreportedLos Angelesvia Arie Belldegrun · board

Reported raises · per SEC filings

Form D private placements
▶$20.2MraisedJun 2024 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean AlgeoExecutive Officer, Promoter
  • Nicole van de LeuvExecutive Officer
  • Helen KimDirector
  • Heba NowyhedExecutive Officer
  • David ChangDirector, Promoter
  • William KaelinDirector
  • Jakob LovenDirector
  • Joshua KazamDirector, Promoter
  • Julie MaltzmanExecutive Officer
  • Mark A. McCamishExecutive Officer, Director
  • John HuynhExecutive Officer
  • David M. TanenExecutive Officer, Promoter
Offering amount
$20.2M
Amount sold
$20.2M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$77MraisedDec 2020 · 47 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David ChangDirector, Promoter
  • Helen KimDirector
  • Sean AlgeoExecutive Officer, Promoter
  • Jakob LovenDirector
  • Mark A. McCamishExecutive Officer, Director
  • Joshua A. KazamDirector
  • David M. TanenExecutive Officer, Promoter
  • Arie S. BelldegrunDirector, Promoter
Offering amount
$77M
Amount sold
$77M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.